ACAna Cristina Calzada-Rascón

Ana Cristina Calzada-Rascón

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana Cristina Calzada-Rascón has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of a Nutritionally Balanced Between-Meal Food Product on Brain Function in Older Adults: Protocol for a Randomized Controlled Trial (the MiniMeal Study)

    by Lina Tingö, Jort Veen, Pernilla Andersson, Myrto Chatzopoulou, Julia Rode, Kristina Andersson, Işılay Kaya, Ana Rascón, Peter Edholm, Robert Brummer, et al.

    Background: Increasing evidence suggests that diet influences gut microbiota composition and systemic inflammation, which in turn may affect brain health, cognitive function, and mood regulation. Elevated levels of systemic inflammation have been associated with reduced resting-state functional connectivity within the default mode network, a pattern linked to poorer cognitive performance in older adults. Dietary interventions incorporating anti-inflammatory foods, such as oat bran and chickpeas, may help attenuate low-grade inflammation and promote healthier dietary behaviors in aging populations. Objective: This study protocol describes a randomized controlled trial designed to investigate the effect of healthy between-meal products on brain activity in older adults. Methods: The MiniMeal study is a 9-week, 3-arm randomized controlled trial comprising a blinded, 2-arm intervention and a nonblinded, no-intervention comparison group. A total of 114 community-dwelling men and women aged ≥70 years (38 per group) will be randomized to 1 of 3 study arms. Participants in the intervention group will consume the MiniMeal products, while those in the reference or control group will receive reference or control products. In both intervention arms, products will be consumed twice daily, either replacing or supplementing habitual morning, afternoon, or evening between-meal occasions. All other dietary habits will remain unchanged. Participants in the no-intervention group will maintain their habitual diet throughout the study period. The primary outcome is functional brain activity, assessed using functional magnetic resonance imaging during the n-back task, comparing the intervention and reference groups. Secondary outcomes include comparisons with the no-intervention group and assessment of other neural measures, biomarkers in blood, body composition, physical function, and self-reported well-being. Results: Ethics approval was obtained from the Swedish Ethical Review Authority (Etikprövningsmyndigheten) on February 20, 2024. Participant recruitment was completed on December 18, 2025. Data collection was completed by February 27, 2026. Data analysis is ongoing since January 7, 2026. A total of 114 participants were enrolled, of whom, 106 completed all 6 study visits. Conclusions: This study will provide insights into whether nutritious between-meal products influence brain function in older adults and will explore potential underlying biological mechanisms. The findings are expected to contribute to a better understanding of the relationship between dietary habits and cognitive health in older adults and may inform future research on diet-based strategies to support in healthy aging. Trial Registration: ClinicalTrials.gov NCT06353984; https://clinicaltrials.gov/study/NCT06353984 International Registered Report Identifier (IRRID): DERR1-10.2196/94648

  • Open Access

    Effects of a Nutritionally Balanced Between-Meal Food Product on Brain Function in Older Adults: Protocol for a Randomized Controlled Trial (the MiniMeal Study) (Preprint)

    by Lina Tingö, Jort Veen, Pernilla Andersson, Myrto Chatzopoulou, Julia Rode, Kristina Andersson, Işılay Kaya, Ana Rascón, Peter Edholm, Robert Brummer, et al.

    BACKGROUND Increasing evidence suggests that diet influences gut microbiota composition and systemic inflammation, which in turn may affect brain health, cognitive function, and mood regulation. Elevated levels of systemic inflammation have been associated with reduced resting-state functional connectivity within the default mode network, a pattern linked to poorer cognitive performance in older adults. Dietary interventions incorporating anti-inflammatory foods, such as oat bran and chickpeas, may help attenuate low-grade inflammation and promote healthier dietary behaviors in aging populations. OBJECTIVE This study protocol describes a randomized controlled trial designed to investigate the effect of healthy between-meal products on brain activity in older adults. METHODS The MiniMeal study is a 9-week, 3-arm randomized controlled trial comprising a blinded, 2-arm intervention and a nonblinded, no-intervention comparison group. A total of 114 community-dwelling men and women aged ≥70 years (38 per group) will be randomized to 1 of 3 study arms. Participants in the intervention group will consume the MiniMeal products, while those in the reference or control group will receive reference or control products. In both intervention arms, products will be consumed twice daily, either replacing or supplementing habitual morning, afternoon, or evening between-meal occasions. All other dietary habits will remain unchanged. Participants in the no-intervention group will maintain their habitual diet throughout the study period. The primary outcome is functional brain activity, assessed using functional magnetic resonance imaging during the n-back task, comparing the intervention and reference groups. Secondary outcomes include comparisons with the no-intervention group and assessment of other neural measures, biomarkers in blood, body composition, physical function, and self-reported well-being. RESULTS Ethics approval was obtained from the Swedish Ethical Review Authority (Etikprövningsmyndigheten) on February 20, 2024. Participant recruitment was completed on December 18, 2025. Data collection was completed by February 27, 2026. Data analysis is ongoing since January 7, 2026. A total of 114 participants were enrolled, of whom, 106 completed all 6 study visits. CONCLUSIONS This study will provide insights into whether nutritious between-meal products influence brain function in older adults and will explore potential underlying biological mechanisms. The findings are expected to contribute to a better understanding of the relationship between dietary habits and cognitive health in older adults and may inform future research on diet-based strategies to support in healthy aging. CLINICALTRIAL ClinicalTrials.gov NCT06353984; https://clinicaltrials.gov/study/NCT06353984 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/94648

  • Open Access

    [Hypereosinophilic syndrome, case report and diagnostic approach].

    by René Medina-Marroquín, José Adrián Espejel-Guzman, Carlos de Jesús Maldonado-López, Ana Cristina Calzada-Rascón

    Hypereosinophilic syndrome (HES) is a rare hematological disorder, characterized by blood and tissue eosinophilia, causing tissue damage and dysfunction. The onset of the disease is generally asymptomatic, being discovered incidentally. The objective of this article is to illustrate the rare clinical presentation in patients with chronic kidney disease. A 69-year-old male patient, with a history of type 2 diabetes and high blood pressure, was admitted to the internal medicine service with wasting syndrome under study, multiple urticarial skin lesions and peripheral blood cytopenias. During the approach to him, eosinophilia of more than 5.0 × 109 / L was evidenced, a bone marrow aspirate was performed, which revealed eosinophilic infiltration with dysplasia, biopsy of dermal lesions with mixed cellular infiltrate with a predominance of eosinophils; With the above, the diagnosis of idiopathic HES is made, after the exclusion of other evident eosinophilia etiologies. Systemic steroid treatment was started. Eosinophilic disorders represent a heterogeneous group of rare conditions, with multiple clinical manifestations, predominantly dermatological. An important association with the development of chronic kidney disease is reported, so a comprehensive approach must be carried out, with the aim of achieving an etiological diagnosis that allows early treatment and improves survival.

  • Open Access

    Sangrado de tubo digestivo alto como presentación clínica del linfoma no Hodgkin

    by René Medina-Marroquín, Iván González-Godínez, Carlos de Jesús Maldonado-López, Ana Cristina Calzada-Rascón

    El linfoma no Hodgkin (LNH) es un grupo de tumores malignos de los tejidos linfoides nodales y extranodales, y está asociado a enfermedades autoinmunes, principalmente artritis reumatoide (AR). La presentación extranodal se observa en el 40% y afecta principalmente el tracto gastrointestinal en el 3% de los casos; el sangrado de tubo digestivo es una causa rara de presentación clínica que requiere un abordaje diagnóstico detallado. mujer de 55 años con antecedente de AR que ingresó a un servicio de medicina interna por sangrado de tubo digestivo; presentó datos clínicos de trombosis venosa profunda en miembro pélvico izquierdo y síndrome consuntivo en estudio. Durante su abordaje se identificó con infartos esplénicos y hepáticos, así como múltiples conglomerados ganglionares, por lo que se practicó biopsia de ganglio axilar que reportó proliferación neoplásica de células linfoides y aspirado de médula ósea con presencia de infiltración linfoplasmocitaria, con lo que se determinó diagnóstico de linfoma no Hodgkin estadio IV. La paciente fue enviada a un hospital de tercer nivel para inicio de tratamiento. este caso nos muestra lo ya descrito en la literatura, por lo que es de fundamental importancia hacer un abordaje integral de los hallazgos clínicos en pacientes con factores de riesgo previamente identificados, con el objetivo de lograr un diagnóstico etiológico que permita una terapéutica temprana para mejorar su sobrevida.